(in millions $) | 1 Dec 2024 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $28.51 | $31.26 | $34.58 | $44.85 |
Inventory | ||||
Total current assets | $194.3 | $210.68 | $218.31 | $224.29 |
Long term investments | ||||
Property, plant & equipment | $12.5 | $10.55 | $10.25 | $10.18 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $222.46 | $235.95 | $242.57 | $247.75 |
Current liabilities | ||||
Accounts payable | $4.72 | $5.03 | $4.07 | $4.87 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $91.17 | $107.1 | $109.55 | $112.51 |
Long term debt | ||||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $95.68 | $109.3 | $113.51 | $117.33 |
Shareholders' equity | ||||
Retained earnings | -$549.7 | -$531.55 | -$511.65 | -$490.66 |
Other shareholder equity | $0.12 | $0.03 | -$0.22 | $0.06 |
Total shareholder equity |
(in millions $) | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 | 3 Mar 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $37.3 | |||
Short term investments | ||||
Net receivables | $44.85 | $39.85 | $36.7 | $35.9 |
Inventory | ||||
Total current assets | $224.29 | $229.48 | $262.99 | $103.54 |
Long term investments | ||||
Property, plant & equipment | $10.18 | $14.37 | $4.29 | $6.51 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $13.65 | |||
Total investments | ||||
Total assets | $247.75 | $253.04 | $276.74 | $117.19 |
Current liabilities | ||||
Accounts payable | $4.87 | $1.41 | $1.92 | $2.43 |
Deferred revenue | $57.17 | |||
Short long term debt | ||||
Total current liabilities | $112.51 | $94.96 | $90.31 | $72.86 |
Long term debt | $24.95 | |||
Total noncurrent liabilities | $290.67 | |||
Total debt | ||||
Total liabilities | $117.33 | $102.78 | $93.53 | $363.53 |
Shareholders' equity | ||||
Retained earnings | -$490.66 | -$410.48 | -$341.98 | -$283.75 |
Other shareholder equity | $0.06 | -$0 | -$0 | $0 |
Total shareholder equity |
(in millions $) | 30 Oct 2025 | 1 Dec 2024 | 31 Aug 2024 | 30 May 2024 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $51.63 | $51.59 | $51.33 | |
Cost of revenue | ||||
Gross Profit | $45.07 | $45.13 | $45.65 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $64.31 | $66.17 | $68.19 | |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $0.69 | $0.56 | -$0.01 | |
Interest expense | -$0.02 | -$0.03 | ||
Net income | ||||
Net income | -$18.15 | -$19.89 | -$21 | |
Income (for common shares) |
(in millions $) | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 | 3 Mar 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $180.04 | $154.8 | $123.54 | $103.28 |
Cost of revenue | ||||
Gross Profit | $157.96 | $134.6 | $108.76 | $91.67 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $237.29 | $202.1 | $165.02 | $125.36 |
Operating income | -$33.08 | |||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $1.35 | $1 | $1.01 | $1.04 |
Interest expense | -$0.84 | -$0.6 | -$0.66 | $6.97 |
Net income | ||||
Net income | -$80.18 | -$68.5 | -$58.23 | -$39.98 |
Income (for common shares) |
(in millions $) | 1 Dec 2024 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $2.88 | $18.28 | $3.69 | $15.43 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $8.77 | $5.93 | $5.09 | $12.93 |
Effect of exchange rate | -$0.33 | -$0.2 | -$0.26 | -$0.56 |
Change in cash and equivalents | -$8.86 | $20.71 | $10.08 | $0.9 |
(in millions $) | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 | 3 Mar 2021 |
---|---|---|---|---|
Net income | -$39.98 | |||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$39.18 | |||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $15.43 | -$23.37 | -$92.03 | -$22.41 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $12.93 | $9.71 | $192.41 | $80.5 |
Effect of exchange rate | -$0.56 | -$0.4 | -$0.41 | $0.16 |
Change in cash and equivalents | $0.9 | -$55.25 | $58.4 | $19.07 |
Market cap | $825.78M |
---|---|
Enterprise value | N/A |
Shares outstanding | 52.26M |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 2.13 |
Quick ratio | N/A |